Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  11.00 3.74% 305.00 302.00 308.00 305.00 292.00 292.00 637,220 11:21:56
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16.3 -9.7 -17.3 - 203

Maxcyte Share Discussion Threads

Showing 201 to 224 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
07/8/2020
11:18
I took another fairly decent quantity (in my terms) today...
multibagger
07/8/2020
10:50
Sahara from twitter is a holder - thread posted last night, so probably some attention from that. volumes been good for a while
nimbo1
07/8/2020
10:23
Steady buying interest continuing....looks like +10p achievable today.
multibagger
06/8/2020
12:39
One way trip...long may it continue.
wantage
04/8/2020
15:22
Bought another 5k, not showing and the previous ,10k never did...?
assagai
04/8/2020
06:12
Good morning timbo003 (and all), Many thanks - you have a PM.
multibagger
03/8/2020
23:04
>>>Multibagger, agree with you about the likely direction of travel, but it might be worth considering buying them in SIPPs rather than ISAs if you are able to. If I recall correctly, you cannot hold unquoted shares in a ISA, although you can in a SIPP, so this could be important if they spin out Carma as an unquoted company before it lists on Nasdaq, which sounds like it could be a possibility based on Doug's comments at the Shares Mag Webinar last week. It's a pity that Shares haven't put up the Maxcyte recording of the Webinar, even though the recordings of the other three presenting companies are all now available. I think I made a recording of it though (somewhere on my PC) so should be able to provide a copy of the Q&As section - just send me a pm if interested
timbo003
03/8/2020
22:52
Ssshhhh. It's a secret!
assagai
03/8/2020
22:08
IMHO, MXCT is just warming up...plenty of steam in the tank. Decent trading activity and price movement upwards in support :) I took another 6918 shares today. Looks like my ISA funds for the family may be finding a home here. Good luck all !
multibagger
03/8/2020
20:49
This is all a complete guess and may prove way out. I would anticipate a £40 mil funding round off 80-100 mil valuation... then the new PE money will float it next year at c.$250 mil valuation. Maxcyte without carma on nasdaq maxcyte could perform very well. Berkeley lights market cap over $4 billion (check it out since float)... their revenue is about $50 mil but I am sure growing v fast. Im at least looking to double my money from here over the next 12 months - but as always might be completely wrong!
nimbo1
03/8/2020
20:32
Jumped on board the train today before it really gets going, would undoubtedly have done so earlier if you could buy this on Barclays, but had to use HL in the end. Still seems like great value compared to US peers... @Nimbo, what do you think Carma could be worth as a spin off?
74tom
03/8/2020
19:11
wonder if funding news is coming soon for carma
nimbo1
23/7/2020
17:42
Thanks Timbo
nimbo1
22/7/2020
19:04
>>>>nimbo re post #193 From my very fuzzy Memory, Doug said something along these lines: When Carma gets spun off, initially there would be a few large VC investors, it could then IPO on Nasdaq (depending on shareholders). Maxcyte would retain a sizable chunk of the Carma shares (30%?) and would remain a shareholder. Maxcyte would remain listed on AIM and go for a second listing on Nasdaq. Carma would be a customer of Maxcyte and pay Maxcyte for services (including milestone payments and royalties) on similar terms to other customers
timbo003
22/7/2020
17:01
It was executed via AIMX so would think it should have shown up. It was 10k so maybe they are holding it back??
assagai
22/7/2020
16:34
It might say the venue on the contract note. I've had trades in BVXP go over Aquis (previously NEX) where it was previously listed. Your trade might have gone via Turqoise or another MTF or maybe it's of a size where the MMs want to hide it from the market with delayed reporting.
gsbmba99
22/7/2020
15:38
Does any one know if this stock is traded on any other platforms apart from LSE ? Only asking as my trade earlier (for which I have received a contract) has not shown up on the monitor or level2. Thanks
assagai
22/7/2020
12:17
Hmm had another bite and tuck away...
assagai
22/7/2020
11:23
Thanks for the update nimbo1. If you haven't already come across it you might be interested in taking a look at the ark invest site hxxps://ark-invest.com/. They are a US fund that specialises in investing in disruptive technologies and one of their favourite plays is genomics. There are a number of short research presentations available for download which run through their investment theses. Retail inflows to their range of ETFs have been very strong. I should add they are also huge bulls on Tesla as well as core licensses of MXCT, most notably CRISPR Therapuetics
rgmgo
22/7/2020
09:33
Look at a US IPO of a company Berkeley Lights - under $50 mil revenue I think and now $3.5 billion market cap. I can see Maxcyte ex carma being worth substantially more than aim pay for it. (and carma could theoretically be worth current market cap or thereabouts on nasdaq) hxxps://www.berkeleylights.com limbo what did they say about the carma spin out - presentation not online yet. Many thanks
nimbo1
21/7/2020
20:48
Doug was presenting again this evening (Shares Mag), a few questions at the end on what happens to Son of Maxcyte (Carma) if the ongoing clinical is successful and what sort of relationship old Maxcyte will have with son of Maxcyte. The recording (and slides) should be available in the next couple of days
timbo003
19/7/2020
20:47
Recording of last week's call: htTps://www.maxcyte.com/investors/results-reports-presentations/corporate-presentations/
rambutan2
18/7/2020
09:21
Many thanks for posting look forward to reading
nimbo1
18/7/2020
06:40
McKinsey article with a lot of scientific/technical information - but well worth spending some time on. Https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/driving-the-next-wave-of-innovation-in-car-t-cell-therapies MXCT appears to address a huge number of the CART related technology and commercial barriers currently in play...
multibagger
Chat Pages: 9  8  7  6  5  4  3  2  1
ADVFN Advertorial
Your Recent History
LSE
MXCT
Maxcyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200807 10:40:46